Bubbles, Stress, Diastole

August 22, 2017 updated by: Dr. med. Claudio Camponovo, Clinica ARS Medica
This is a monocentric pilot study to assess the safety profile of a 30-meter deep underwater diving using 3 different type of gas mixtures: AIR (21% O2 and 79% N2), NITROX 32 (32% O2 And 68% N2) and TRIMIX (21% O2, 44% N2 and 35% He).

Study Overview

Detailed Description

The participants will be measured for vital parameters, blood samples and transthoracic cardiac ultrasound before diving (baseline).

Participants will be requested to perform recreational dive, which does not require particular decompression stops, at a depth of 30 meters with a 30 minutes botton time. 20 minutes after dive the same measurements as baseline will be repeated, once at rest and once after a physical effort by performing a series of 10 bending on the legs (squats). The day after dive, the participants will be interviewed by phone (FOLLOW-UP) by a physician. It will be required to report any unusual event, MDD symptom, or neurological complication.

Same procedure will be repeated with three different type of blends (AIR, NITROX, TRIMIX).

Study Type

Observational

Enrollment (Anticipated)

4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healty volunteer divers

Description

Inclusion Criteria:

  • Age 18 - 60
  • healthy subjects
  • body mass BMI < a 30
  • physical status ASA 1

Exclusion Criteria:

  • subjects with significant clinical impairments such as important head trauma, general pain, low back pain, diabetes, asthma, cardiac and coagulation dysfunctions
  • pregnant women
  • participation in another study in the last 3 months
  • use of drugs and alcohol
  • smoking
  • psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1
Three dives with different gas mixture : AIR (21% di O2 e 79% di N2), NITROX 32 (32% di O2 e 68% di N2) and TRIMIX (21% O2, 44% N2 e 35% He)
Diagnostic test done prior and after the dive
Diagnostic test done prior and after the dive

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Best gas mixture
Time Frame: 1 month
Best gas mixture with minimal cardiac function impact (endothelial stress)
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
diastolic function evaluation
Time Frame: 1 month
diastolic function evaluated after a dive with three different gas mixtures
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 11, 2017

Primary Completion (Actual)

July 6, 2017

Study Completion (Anticipated)

August 31, 2017

Study Registration Dates

First Submitted

June 28, 2017

First Submitted That Met QC Criteria

July 5, 2017

First Posted (Actual)

July 6, 2017

Study Record Updates

Last Update Posted (Actual)

August 23, 2017

Last Update Submitted That Met QC Criteria

August 22, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • CMAS1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endothelial Dysfunction

Clinical Trials on Transthoracic echocardiography

3
Subscribe